Covid-19 Vaccine Trial
-
{
- All
- News
- Videos
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
Roche Joins Moderna To Include Antibody Test In COVID-19 Vaccine Trial
Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially demonstrating if the vaccine is working.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Oxford COVID-19 Vaccine Trials Produce Robust Immune Response In Elderly: Report
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
2 Mumbai Hospitals Begin Phase 2, 3 Trials Of Oxford Covishield Vaccine For COVID-19: Report
The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.
-
China, UAE See Positive Results In Phase 3 COVID-19 Vaccine Trials, Says Official
China and the United Arab Emirates have seen some positive results in their Phase III COVID-19 vaccine trials, Chinese foreign ministry spokesman Wang Wenbin told a news briefing in Beijing on Monday.
-
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
-
"Wanted To Be Part Of Fight Against COVID-19": Vaccine Trial Volunteer
A Pune doctor who volunteered for COVID-19 vaccine trial, says he was inspired by Louis Pasteur and Edward Jenner, pioneer immunologists. He said his vital signs are normal and he has resumed routine work.
-
Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study
Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.
-
Roche Joins Moderna To Include Antibody Test In COVID-19 Vaccine Trial
Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially demonstrating if the vaccine is working.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Oxford COVID-19 Vaccine Trials Produce Robust Immune Response In Elderly: Report
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.
-
Third Phase Human Trial Of Covid-19 Vaccine To Begin In Bhubaneswar Soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital soon, an official said.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
-
2 Mumbai Hospitals Begin Phase 2, 3 Trials Of Oxford Covishield Vaccine For COVID-19: Report
The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.
-
China, UAE See Positive Results In Phase 3 COVID-19 Vaccine Trials, Says Official
China and the United Arab Emirates have seen some positive results in their Phase III COVID-19 vaccine trials, Chinese foreign ministry spokesman Wang Wenbin told a news briefing in Beijing on Monday.
-
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
-
"Wanted To Be Part Of Fight Against COVID-19": Vaccine Trial Volunteer
A Pune doctor who volunteered for COVID-19 vaccine trial, says he was inspired by Louis Pasteur and Edward Jenner, pioneer immunologists. He said his vital signs are normal and he has resumed routine work.
